MANABU FUKUMOTO, 2 JUN FUJITA, 3 AND MASAYUKI IMAMURA 1 liver tumors, whereas basic FGF may be involved in the Hepatocellular carcinoma (HCC) is a typical hypervasinvasion of HCC into the surrounding tissues. (HEPATOLcular tumor. However, the relationship between the vas-OGY 1996;23:455-464.) culari
Endostatin variations in childhood acute lymphoblastic leukaemia—Comparison with basic fibroblast growth factor and vascular endothelial growth factor
✍ Scribed by P. Schneider; M. Vasse; C. Corbière; E. Legrand; A. Marie-Cardine; C. Boquet; L. Cazin; J.P. Vannier
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 538 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0145-2126
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Angiogenesis is a possible target in the treatment of human gliomas. To evaluate the role of 3 growth factors, vascular endothelial growth factor (VEGF), hepatocyte growth factor/scatter factor (HGF/SF) and basic fibroblast growth factor (bFGF), in the angiogenic cascade, we determined their levels
Vascular endothelial growth factor-C (VEGF-C) is a recently characterized member of the VEGF family of angiogenic polypeptides. We demonstrate here that VEGF-C is angiogenic in vitro when added to bovine aortic or lymphatic endothelial (BAE and BLE) cells but has little or no effect on bovine microv
Angiogenesis seems to be important both in the pathogenesis of acute myelogenous leukemia (AML) and for the susceptibility of AML blasts to chemotherapy. Recent clinical studies even suggest that antiangiogenic therapy can induce disease control in patients with AML relapse. In this context we have
## Abstract We have previously shown experimental transplantation of living allogeneic bone to be feasible without long‐term immunosuppression by development of a recipient‐derived neoangiogenic circulation within bone. In this study, we examine the role of angiogenic cytokine delivery with biodegr